ArticleBlood2022

PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.

Swagata Goswami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.